| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/27/2023 | Fulcrum Therapeutics, Inc. | FULC | Grant | Stock Option (right to buy) | 30k | $3.16 | $94.8k | | 06/27/2023 |
| 06/14/2023 | Orchard Therapeutics plc | ORTX | Grant | Stock Option (Right to Buy) | 105k | $0.50 | $52k | | 06/14/2023 |
| 06/06/2023 | Voyager Therapeutics, Inc. | VYGR | Grant | Stock Option (Right to Buy) | 22k | $12.57 | $276.5k | | 06/06/2023 |
| 06/27/2022 | Fulcrum Therapeutics, Inc. | FULC | Grant | Stock Option (right to buy) | 19k | $5.22 | $99.2k | | 06/27/2022 |
| 06/23/2022 | Aceragen, Inc. | IDRA | Grant | | 26k | $0.46 | $11.9k | | 06/23/2022 |
| 06/22/2022 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 45k | $1.82 | $81.9k | | 06/22/2022 |
| 06/07/2022 | Orchard Therapeutics plc | ORTX | Grant | Stock Option (Right to Buy) | 46k | $0.47 | $21.8k | | 06/07/2022 |
| 06/06/2022 | Voyager Therapeutics, Inc. | VYGR | Grant | Stock Option (Right to Buy) | 22k | $5.27 | $115.9k | | 06/06/2022 |
| 06/28/2021 | Fulcrum Therapeutics, Inc. | FULC | Purchase | Common Stock | 10k | $9.16 | $91.6k | | 06/28/2021 |
| 06/25/2021 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 45k | $4.00 | $180k | | 06/25/2021 |
| 06/16/2021 | Orchard Therapeutics plc | ORTX | Grant | Stock Option (Right to Buy) | 40k | $4.79 | $191.6k | | 06/16/2021 |
| 06/09/2021 | Fulcrum Therapeutics, Inc. | FULC | Grant | Stock Option (right to buy) | 15k | $8.85 | $132.8k | | 06/09/2021 |
| 06/08/2021 | Aceragen, Inc. | IDRA | Grant | | 26k | $1.31 | $34.1k | | 06/08/2021 |
| 06/03/2021 | Voyager Therapeutics, Inc. | VYGR | Grant | Stock Option (Right to Buy) | 15k | $4.23 | $63.4k | | 06/03/2021 |
| 04/01/2021 | Aceragen, Inc. | IDRA | Grant | Common Stock | 14.8k | $1.32 | $19.5k | | 04/01/2021 |
| 01/04/2021 | Aceragen, Inc. | IDRA | Grant | Common Stock | 4.9k | $4.02 | $19.5k | | 01/04/2021 |
| 10/01/2020 | Aceragen, Inc. | IDRA | Grant | Common Stock | 8.7k | $2.25 | $19.5k | | 10/01/2020 |
| 07/01/2020 | Aceragen, Inc. | IDRA | Grant | Common Stock | 10.9k | $1.79 | $19.5k | | 07/01/2020 |
| 06/23/2020 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 45k | $3.27 | $147.2k | | 06/23/2020 |
| 06/17/2020 | Orchard Therapeutics plc | ORTX | Grant | Stock Option (Right to Buy) | 35k | $7.81 | $273.4k | | 06/17/2020 |
| 06/11/2020 | Fulcrum Therapeutics, Inc. | FULC | Grant | Stock Option (right to buy) | 9.3k | $17.63 | $163.7k | | 06/11/2020 |
| 06/04/2020 | Voyager Therapeutics, Inc. | VYGR | Grant | Stock Option (Right to Buy) | 15k | $11.79 | $176.8k | | 06/04/2020 |
| 05/12/2020 | Aceragen, Inc. | IDRA | Grant | | 14.5k | $1.97 | $28.6k | | 05/12/2020 |
| 04/01/2020 | Aceragen, Inc. | IDRA | Grant | Common Stock | 14.9k | $1.28 | $19.1k | | 04/01/2020 |
| 01/25/2020 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 22.5k | $3.23 | $72.7k | | 01/25/2020 |
| 07/18/2019 | Fulcrum Therapeutics, Inc. | FULC | Grant | Stock Option (right to buy) | 9.3k | $16.00 | $148.6k | | 07/18/2019 |
| 06/13/2019 | Voyager Therapeutics, Inc. | VYGR | Grant | Stock Option (Right to Buy) | 15k | $24.68 | $370.2k | | 06/13/2019 |
| 06/04/2019 | Aceragen, Inc. | IDRA | Grant | | 14.5k | $2.57 | $37.3k | | 06/04/2019 |
| 01/25/2019 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 25k | $2.74 | $68.5k | | 01/25/2019 |
| 09/10/2018 | Voyager Therapeutics, Inc. | VYGR | Purchase | Common Stock | 3k | $19.39 | $58.2k | | 09/10/2018 |
| 08/17/2018 | Voyager Therapeutics, Inc. | VYGR | Purchase | Common Stock | 3k | $18.31 | $54.9k | | 08/17/2018 |
| 08/14/2018 | JUNIPER PHARMACEUTICALS INC | JNP | Disposition | Employee Stock Option (right to buy) | 70k | $7.51 | $525.7k | | 08/14/2018 |
| 08/14/2018 | JUNIPER PHARMACEUTICALS INC | JNP | Disposition | Common Stock | 80.7k | $11.50 | $928.6k | | 08/14/2018 |
| 08/14/2018 | JUNIPER PHARMACEUTICALS INC | JNP | Disposition | Stock Option (right to buy) | 30k | $5.15 | $154.5k | | 08/14/2018 |
| 08/07/2018 | Aceragen, Inc. | IDRA | Purchase | Common Stock | 10k | $5.58 | $55.8k | | 08/07/2018 |
|